home / stock / hims / hims articles


HIMS Articles, Hims & Hers Health Inc. Class A

Stock Information

Company Name: Hims & Hers Health Inc. Class A
Stock Symbol: HIMS
Market: NYSE
Website: forhims.com

Menu

HIMS HIMS Quote HIMS Short HIMS News HIMS Articles HIMS Message Board
Get HIMS Alerts

News, Short Squeeze, Breakout and More Instantly...

Should You Keep Chemed Stock in Your Portfolio Now? | Benzinga

Chemed Corporation (NYSE: CHE) is primed to grow in the upcoming quarters, backed by the promising prospects of the VITAS business. The compan...

Quest Diagnostics Set to Acquire OhioHealth's Lab Services | Benzinga

Quest Diagnostics (NYSE: DGX) recently announced a definitive agreement to purchase the select assets of OhioHealth's outreach laboratory servi...

3 Companies Set to Positively Surprise this Earnings Season | Benzinga

Earnings season has arrived, with Friday's big bank results shifting the period into a much higher gear. The period looks to be positive, with ...

Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks were higher, with the Nasdaq Composite index gaining around 100 points on Friday. Shares of The Bank of New York Mellon Corporation (NY...

Here's Why Holding Align Technology Stock Could Pay Off | Benzinga

Align Technology, Inc's (NASDAQ: ALGN) successful efforts to broaden the Invisalign portfolio are poised to bring significant growth in th...

Here's Why Staying Invested in Neogen Could be Beneficial | Benzinga

Neogen Corporation (NASDAQ: NEOG) effectively progresses with its strategic growth pillars, placing the company well for future success. The A...

Quest Diagnostics to Expand in Canada With LifeLabs Buyout | Benzinga

Quest Diagnostics (NYSE: DGX) has entered into a definitive agreement with OMERS to acquire LifeLabs, a prominent Canadian provider of community la...

Neuronetics Expands NeuroStar Portfolio With New Launch | Benzinga

Neuronetics, Inc. (NASDAQ: STIM) recently announced the nationwide launch of the Better Me Provider (BMP) program. The BMP program will be a part o...

Is It the Right Time to Hold Labcorp in Your Portfolio? | Benzinga

Laboratory Corporation of America Holdings (NYSE: LH), or Labcorp's, focused efforts in the high-growth areas position it for strong growth in ...

QIAGEN Backs New AAP Guidelines Supporting QFT-Plus Test | Benzinga

QIAGEN N.V. (NYSE: QGEN) recently lauded the new guidelines in the United States that recommend screening at-risk children of all ages for lat...

Next 10